A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malaria

Chinese Journal of Integrative Medicine

Volumn 15, Issue 3, 2009, Pages 189-192

  Trung, Trieu Nguyen ^a   Tan, Bo ^b   Van Phuc, Dang ^a   Song, Jian Ping ^b  

^a MINISTRY OF HEALTH   (Viet Nam)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Antimalarials; Artemisinin; Malaria; Piperaquine; Plasmodium falciparum; Randomized controlled trial

Indexed keywords

ARTEMISININ; ARTEQUICK; DIHYDROARTEMISININ PLUS PIPERAQUINE; PIPERAQUINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANOREXIA; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHEMOTHERAPY INDUCED EMESIS; CHILD; CLEARANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; FEVER; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MENTAL DISEASE; NAUSEA; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARASITE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; FEMALE; HUMANS; INTEGRATIVE MEDICINE; MALARIA, FALCIPARUM; MALE; QUINOLINES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67650505663     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11655-009-0189-6     Document Type: Article

References (10)

1. Jose A. Najera, Joahim Hempel. The burden of malaria, CTD/MAL/96.10. http://www.rbm.who.int/cmc-upload/0/000/009/511/burden-najera.pdf
2. WHO. World malaria report. Geneva: World Health Organization; 2005. http://www.unicef.org/media/files/MalariaFactSheet.pdf
3. WHO. Guidelines for the treatment of malaria. Geneva: World Health Organization; 2006. http://whqlibdoc.who.int/publications/2006/9241546948-eng. pdf
4. WHO. Assessment and monitoring of Antimalarial drug efficacy for the treatment of uncompcicated falciparum malaria. Geneva: World Health Organization; 2003. http://www.who.int/malaria/docs/ProtocolWHO.pdf
5. Song JP, Socheat D, Seila S, Tharith T, Satim S, Yuthease S, et al. Clinical observation of dihydroartemisinin-piperaquine phosphate in treatment of uncomplicated falciparum malaria. Natl Med J Chin (Chin) 2003;83: 1099-1100.
6. Karema C, Fanello CI, van Overmeir C, van Geertruyden JP, van Doren W, Ngamije D, et al. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated plasmodium falciparum malaria in Rwandan children. Trans R Soc Trop Med Hyg 2006;100:1105-1111. (Pubitemid 44464010)
7. Tangpukdee N, Krudsood S, Thanachartwet W, Chalermrut K, Pengruksa C, Srivilairit S, et al. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast Asian J Trop Med Public Health 2005;36:1085-1091. (Pubitemid 43058822)
8. Song JP, Fu LC, Tan B, Li GQ. Randomized controlled trial of dihydroartemisinin piperaquine phosphate tablets in treatment of uncomplicated falciparum malaria. Chin J New Drugs (Chin) 2004;11: 783-785. (Pubitemid 39604968)
9. Chen L, Qu FY, Zhou YC. Field observation on the antimalarial piperaquine. Chin J Med (Chin) 1982; 95:281-286.
10. Tran TH, Dolecek C, Pham PM, Nguyen TD, Nguyen TT, Le HT, et al. Dihydroartemisinin-piperaquine against multidrug-resistant plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 2004;363:18-22. (Pubitemid 38076920)